NCT06145100View on ClinicalTrials.gov

Prediction of Portal Hypertension in Patients With CVID (CVID-pHT)

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Non-Cirrhotic Portal HypertensionCommon Variable Immunodeficiency
Interventions
DIAGNOSTIC_TEST

Ultrasound including color doppler ultrasound

Patients with CVID receive color doppler ultrasound of the liver including assessment of portal vein diameter, portal vein flow velocity, hepatic vein diameter and assessment of arterial perfusion. Further liver and spleen stiffness measurement by transient elastography is performed.

Trial Locations (1)

79106

RECRUITING

University Medical Center Freiburg, Department of Medicine II, Freiburg im Breisgau

All Listed Sponsors
lead

University Hospital Freiburg

OTHER